JRSIS HEALTH CARE Corp (JRSS) Financial Statements (2023 and earlier)
Company Profile
Business Address |
3/F BUILDING A, DERUN YUAN WUGUISHAN, ZHONGSHAN CITY, 528458 |
State of Incorp. | FL |
Fiscal Year End | December 31 |
Industry (SIC) | 806 - Hospitals (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 59 | 11 | 38 | 1,947 | 856 | 528 | 313 | ||
Cash and cash equivalents | 59 | 11 | 38 | 1,947 | 856 | 528 | 313 | ||
Receivables | 4 | 3 | 17 | 8,849 | 7,882 | 9,158 | 6,822 | ||
Inventory, net of allowances, customer advances and progress billings | 1,745 | 1,771 | 1,745 | 1,178 | |||||
Inventory | 1,745 | 1,771 | 1,745 | 1,178 | |||||
Prepaid expense | 4,214 | 2,812 | 996 | ||||||
Deferred costs | 736 | 818 | 900 | 399 | 461 | 454 | 457 | ||
Other undisclosed current assets | 84 | 270 | 273 | ||||||
Total current assets: | 799 | 832 | 955 | 17,154 | 13,866 | 12,154 | 10,040 | ||
Noncurrent Assets | |||||||||
Finance lease, right-of-use asset, after accumulated amortization | 16,520 | 14,860 | |||||||
Operating lease, right-of-use asset | 22 | 27 | 3,711 | 3,967 | |||||
Property, plant and equipment | 39 | 40 | 45 | 34,379 | 33,163 | 32,483 | 32,028 | ||
Deposits noncurrent assets | 970 | 968 | 953 | 581 | |||||
Deferred costs | 2,065 | 2,118 | 2,200 | 2,300 | |||||
Other undisclosed noncurrent assets | 18 | 26,597 | 25,578 | 2,975 | 1,438 | ||||
Total noncurrent assets: | 57 | 61 | 71 | 64,011 | 61,827 | 58,842 | 55,173 | ||
TOTAL ASSETS: | 856 | 894 | 1,026 | 81,165 | 75,693 | 70,996 | 65,213 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 27 | 11 | 11 | 18,477 | 15,391 | 11,977 | 10,579 | ||
Taxes payable | ✕ | ✕ | ✕ | 967 | 421 | 564 | |||
Employee-related liabilities | ✕ | 1 | 2 | 1,087 | 1,059 | 1,164 | 1,123 | ||
Accounts payable | 25 | 8 | 8 | 14,369 | 12,432 | 10,812 | 8,892 | ||
Accrued liabilities | 2 | 1 | 2 | 2,054 | 1,479 | ||||
Debt | 631 | 629 | 280 | 389 | |||||
Due to related parties | 2 | 37 | 1 | 1,534 | 100 | ||||
Other liabilities | 76 | ||||||||
Other undisclosed current liabilities | 17 | 15 | 15 | 1,056 | 1,578 | 3,911 | 3,285 | ||
Total current liabilities: | 43 | 28 | 26 | 20,277 | 17,600 | 17,701 | 14,353 | ||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 1 | 6 | 10 | 20,665 | 20,998 | 18,038 | 16,753 | ||
Long-term debt, excluding current maturities | 618 | 617 | 607 | 607 | |||||
Finance lease, liability | 1 | 6 | 10 | 20,046 | 20,381 | 17,431 | 16,145 | ||
Liabilities, other than long-term debt | 4,274 | 3,993 | 3,806 | 3,201 | |||||
Deferred income tax liabilities | 4,274 | 3,993 | 3,806 | 3,201 | |||||
Other undisclosed noncurrent liabilities | 0 | 3 | 8 | ||||||
Total noncurrent liabilities: | 1 | 6 | 10 | 24,939 | 24,991 | 21,847 | 19,961 | ||
Total liabilities: | 45 | 33 | 37 | 45,215 | 42,591 | 39,548 | 34,314 | ||
Equity | |||||||||
Equity, attributable to parent | 811 | 861 | 989 | 24,064 | 22,068 | 20,829 | 20,453 | ||
Common stock | 58 | 58 | 58 | 19 | 19 | 19 | 19 | ||
Additional paid in capital | 24,453 | 24,453 | 24,453 | 23,381 | 23,381 | 23,381 | 23,381 | ||
Accumulated other comprehensive income | 6 | 10 | 6 | 695 | 545 | 176 | 169 | ||
Accumulated deficit | (23,706) | (23,660) | (23,528) | (30) | (1,877) | (2,747) | (3,116) | ||
Equity, attributable to noncontrolling interest | 11,885 | 11,034 | 10,619 | 10,446 | |||||
Total equity: | 811 | 861 | 989 | 35,949 | 33,102 | 31,448 | 30,899 | ||
TOTAL LIABILITIES AND EQUITY: | 856 | 894 | 1,026 | 81,165 | 75,693 | 70,996 | 65,213 |
Income Statement (P&L) ($ in thousands) Annual | Quarterly
12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 89 | 15,619 | 13,165 | 12,159 | 11,741 | |||
Cost of revenue (Cost of Goods and Services Sold) | (1,101) | (864) | (838) | (804) | ||||
Gross profit: | 14,519 | 12,302 | 11,321 | 10,937 | ||||
Operating expenses | 26 | (219) | (133) | (12,045) | (11,958) | (11,424) | (10,308) | |
Other undisclosed operating income (loss) | (70) | 86 | 6 | 1,101 | 886 | 838 | 804 | |
Operating income (loss): | (44) | (132) | (127) | 3,574 | 1,230 | 734 | 1,433 | |
Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (7) | 304 | (1) | (33) | ||||
Interest and debt expense | (407) | (305) | (345) | (441) | ||||
Other undisclosed loss from continuing operations before equity method investments, income taxes | (2) | |||||||
Income (loss) from continuing operations before equity method investments, income taxes: | (46) | (132) | (127) | 3,161 | 1,229 | 389 | 959 | |
Other undisclosed income from continuing operations before income taxes | 407 | 305 | 345 | 441 | ||||
Income (loss) from continuing operations before income taxes: | (46) | (132) | (127) | 3,567 | 1,534 | 734 | 1,400 | |
Income tax expense | (928) | (406) | (192) | (377) | ||||
Income (loss) from continuing operations: | (46) | (132) | (127) | 2,639 | 1,128 | 541 | 1,023 | |
Income (loss) before gain (loss) on sale of properties: | ✕ | (132) | (36,182) | 2,639 | 1,128 | 541 | 1,023 | |
Loss from discontinued operations | (36,055) | |||||||
Net income (loss): | (46) | (132) | (36,182) | 2,639 | 1,128 | 541 | 1,023 | |
Net income (loss) attributable to noncontrolling interest | 34,985 | (792) | (259) | (173) | (357) | |||
Other undisclosed net income attributable to parent | 36,055 | 1,070 | 792 | 957 | 173 | 357 | ||
Net income (loss) attributable to parent: | 36,009 | (132) | (127) | 2,639 | 1,826 | 541 | 1,023 | |
Other undisclosed net loss available to common stockholders, basic | (792) | (957) | (173) | (357) | ||||
Net income (loss) available to common stockholders, diluted: | 36,009 | (132) | (127) | 1,847 | 870 | 369 | 666 |
Comprehensive Income ($ in thousands)Annual | Quarterly
12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (46) | (132) | (36,182) | 2,639 | 1,128 | 541 | 1,023 | |
Other undisclosed comprehensive income (loss) | (4) | 4 | 111 | |||||
Comprehensive income (loss): | (49) | (129) | (36,071) | 2,639 | 1,128 | 541 | 1,023 | |
Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 34,985 | (851) | (415) | (173) | (497) | |||
Other undisclosed comprehensive income, net of tax, attributable to parent | 34,985 | 208 | 526 | 7 | 472 | |||
Comprehensive income (loss), net of tax, attributable to parent: | 34,935 | (129) | (1,086) | 1,996 | 1,239 | 376 | 997 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.